PsoProtectMe is working together with case reporting registries of COVID-19 in other diseases, in order to better understand the impact of the pandemic. We are also working closely with existing psoriasis registries that monitor the long term safety of treatments, to support the timely and detailed reporting of cases of COVID-19.
If you are involved in a registry, and would be interested in linking to us, please do contact us.
PsoProtectMe Study Team
The PsoProtectMe team is a group of doctors and scientists at St John’s Institute of Dermatology, Guy’s and St Thomas’ Hospital London; the Dermatology Centre, University of Manchester; and patient representatives from the Psoriasis Association (UK). The PsoProtectMe team is supported by global professional and patient organizations and PsoProtect’s expert international scientific advisory board.
Dr. Satveer Mahil
Prof. Chris Griffiths
Prof. Jonathan Barker
Prof. Catherine Smith
Prof. Lars Iversen (Denmark)
Prof. Herve Bachelez (France)
Prof. Phyllis Spuls (Netherlands)
Prof. Claudia de la Cruz (Chile)
Prof. Nick Reynolds (UK)
Prof. Luigi Naldi (Italy)
Prof. Joel Gelfand (USA)
Prof. Choon Siew (Malaysia)
We are working closely with healthcare professionals all over the world to understand how the COVID-19 pandemic is affecting people with psoriasis. Information from clinicians is collected in the PsoProtect registry.